AI-guided surgery for early-stage bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether artificial intelligence (AI) can help guide surgeons during a procedure called TURBT to remove early-stage bladder cancer. The goal is to see if this technology improves the removal of cancer while potentially reducing risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have been diagnosed with non-muscle invasive bladder cancer (cancer that has not spread into the bladder muscle) based on imaging or a scope exam.
- You must be healthy enough to undergo TURBT surgery.
- You must be willing to give written consent to participate.
- You cannot be pregnant or breastfeeding.
- You cannot have severe organ dysfunction, distant cancer spread, or serious infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an artificial-intelligence (AI) system during real-time bladder evaluation to better spot bladder tumors. It may help your care team find tumors more accurately during diagnosis or follow-up.
This trial tests an AI-assisted camera system that looks inside the bladder to help find bladder cancer. It may help diagnose cancer more accurately during a routine procedure.
This trial tests whether an AI-powered camera system helps find bladder cancer better than a standard camera during a cystoscopy. If you are an adult with suspected new or returning bladder cancer, you may be able to join.
This trial uses artificial intelligence to look at ultrasound and other scans to better stage bladder cancer and predict if chemotherapy before surgery might work. It may help doctors plan your treatment more precisely.
This trial uses an artificial intelligence model to analyze CT scans taken before bladder removal surgery. The goal is to see if the AI can predict outcomes for patients with muscle-invasive bladder cancer.
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.